Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia J. Hey is active.

Publication


Featured researches published by Patricia J. Hey.


FEBS Letters | 1993

Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells

George McAllister; Michael R. Knowles; Shil Patel; Rosemarie Marwood; Frances Emms; Guy R. Seabrook; Michael P. Graziano; Doreen A. Borkowski; Patricia J. Hey; Stephen B. Freedman

The D2 dopamine receptor is known to be functionally coupled when expressed in CHO cells, whereas the effector systems for the D3, dopamine receptor remain unclear. A chimeric, human D3/D2 receptor (hD3/D2) was constructed containing the third intracellular loop region of the D2 receptor. CHO cells stably expressing the D2, D3, or hD3/D2 receptors were created and the pharmacology of the receptors was examined. The chimeric hD3/D2 receptor retained D3‐like affinities for dopaminergic ligands. However, in contrast to the D2 receptor neither the D3 receptor nor the hD3/D2 receptor could functionally couple to the adenylate cyclase or arachidonic acid release mechanisms.


Journal of Biological Chemistry | 1997

Alterations in Receptor Activation and Divalent Cation Activation of Agonist Binding by Deletion of Intracellular Domains of the Glucagon Receptor

Gary G. Chicchi; Michael P. Graziano; Greg Koch; Patricia J. Hey; Kathleen A. Sullivan; Pasquale P. Vicario; Margaret A. Cascieri

Deletion of residues 252-259 within the putative second intracellular loop of the human glucagon receptor results in a protein with high affinity for glucagon but with attenuated agonist activation of adenylyl cyclase. The Δ252-259 mutant has 4-fold higher affinity for glucagon than does the wild type receptor. The nonhydrolyzable GTP analog, guanosine 5′-(β,γ-imido)triphosphate (Gpp(NH)p), inhibits binding of 125I-glucagon to the wild type receptor but not to the Δ252-259 mutant. Divalent cations such as MgCl2 and CaCl2 stimulate the binding of 125I-glucagon to the wild type receptor by increasing glucagon affinity. The rate of dissociation of 125I-glucagon is decreased 4-fold by MgCl2 and increased 6-fold by Gpp(NH)p. However, divalent cations do not affect the binding of 125I-glucagon to the Δ252-259 mutant. The rate of dissociation of 125I-glucagon from the Δ252-259 mutant protein is equivalent to the rate of dissociation from the wild type receptor in the presence of MgCl2. These data suggest that at least three conformations of the glucagon receptor can exist in the membrane based on their differing affinities for 125I-glucagon. Deletion of residues 252-259 appears to lock the protein in the conformation promoted by divalent cations and prevents the protein from normal coupling to Gs.


Archives of Biochemistry and Biophysics | 1991

PHYSICOCHEMICAL CHARACTERIZATION OF BOVINE RETINAL ARRESTIN

Susan Kotake; Patricia J. Hey; Raghavendra G. Mirmira; Robert A. Copeland

The native conformation of bovine retinal arrestin has been characterized by a variety of spectroscopic methods. The purified protein gives rise to a near uv absorption band centered at 279 nm which results from the absorbance of its 14 tyrosine and one tryptophan residue. The extinction coefficient for this absorption band was determined to be 38.64 mM-1, cm-1 using the tyrosinate-tyrosine difference spectrum method; this extinction coefficient is ca. 17% lower than the previously reported value, and provides estimates of protein concentration which are in good agreement with estimates from the Bradford colorimetric assay. When native arrestin is purified to homogeneity, it displays a fluorescence spectrum which is dominated by tyrosine emission with no discernible contribution from tryptophan. Observation of the tyrosine-like fluorescence is dependent on the purity and structural integrity of the protein. Denaturation of arrestin by guanidine hydrochloride results in a diminution of tyrosine fluorescence and the concomitant appearance of a second fluorescence maximum at ca. 340 nm, presumably due to the single tryptophan residue. Thermal denaturation of arrestin leads to a conformation characterized by a broad fluorescence band centered at ca. 325 nm. Study of the arrestin fluorescence spectrum as a function of temperature indicates that the thermal denaturation is well modeled as a two-state transition with a transition midpoint of 60 degrees C. Temperature-dependent far uv circular dichroism studies indicate that changes in secondary structure occur coincident with the change in fluorescence. Studies of the temperature dependence of arrestin binding to light-adapted phosphorylated rhodopsin shows a strong correlation between the fluorescence spectral features of arrestin and its ability to bind rhodopsin. These data suggest that the relative intensities of tyrosine and tryptophan fluorescence are sensitive to the structural integrity of the native (i.e., rhodopsin binding) state of arrestin, and can thus serve as useful markers of conformational transitions of this protein. The lack of tryptophan fluorescence for native arrestin suggests an unusual environment for this residue. Possible mechanisms for this tryptophan fluorescence quenching are discussed.


Nature Genetics | 1996

LEPTIN RECEPTOR MISSENSE MUTATION IN THE FATTY ZUCKER RAT

Michael Sean Phillips; Qingyun Liu; Holly A. Hammond; Valarie Dugan; Patricia J. Hey; C. Thomas Caskey; J. Fred Hess


Journal of Biological Chemistry | 1996

Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice

Bei Zhang; Michael P. Graziano; Thomas W. Doebber; Mark D. Leibowitz; Sylvia White-Carrington; Deborah Szalkowski; Patricia J. Hey; Margaret Wu; Catherine A. Cullinan; Philip J. Bailey; Bettina Löllmann; Robert C. Frederich; Jeffrey S. Flier; Catherine D. Strader; Roy G. Smith


Endocrinology | 1996

Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells

Charles Rosenblum; Michael R. Tota; Doris F. Cully; Timothy Smith; R Collum; S Qureshi; J. F. Hess; M S Phillips; Patricia J. Hey; Aurawan Vongs; Tung Ming Fong; L Xu; Howard Y. Chen; Roy G. Smith; C Schindler; L.H.T Van der Ploeg


Biochemical and Biophysical Research Communications | 1994

Cloning and Expression of a Human Glucagon Receptor

Douglas J. MacNeil; J.L. Occi; Patricia J. Hey; Catherine D. Strader; Michael P. Graziano


Biochemical and Biophysical Research Communications | 1993

Cloning and functional expression of a human glucagon-like peptide-1 receptor.

Michael P. Graziano; Patricia J. Hey; Doreen A. Borkowski; Gary G. Chicchi; Catherine D. Strader


Protein Expression and Purification | 1998

Production of Leptin inEscherichia coli:A Comparison of Methods

Jeffrey P. Varnerin; Timothy Smith; Charles Rosenblum; Aurawan Vongs; Beth Ann Murphy; Chris Nunes; Theodore N. Mellin; Joseph J. King; Bruce Burgess; Beth Junker; Michael Chou; Patricia J. Hey; Easter G. Frazier; D. Euan MacIntyre; Lex H.T. Van der Ploeg; Michael R. Tota


Archive | 1997

OB receptor isoforms and nucleic acids encoding them

C. Thomas Caskey; Patricia J. Hey; John W. Hess; Michael Sean Phillips

Collaboration


Dive into the Patricia J. Hey's collaboration.

Researchain Logo
Decentralizing Knowledge